Cargando…
Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt(ii)-induced nucleolar stress
Pt(ii) chemotherapeutic complexes have been used as predominant anticancer drugs for nearly fifty years. Currently there are three FDA-approved chemotherapeutic Pt(ii) complexes: cisplatin, carboplatin, and oxaliplatin. Until recently, it was believed that all three complexes induced cellular apopto...
Autores principales: | Guerrero, Andres S., O’Dowd, Paul D., Pigg, Hannah C., Alley, Katelyn R., Griffith, Darren M., DeRose, Victoria J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549245/ https://www.ncbi.nlm.nih.gov/pubmed/37799581 http://dx.doi.org/10.1039/d3cb00055a |
Ejemplares similares
-
Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin
por: Sutton, Emily C., et al.
Publicado: (2021) -
Oxaliplatin disrupts nucleolar function through biophysical disintegration
por: Broder Schmidt, H., et al.
Publicado: (2022) -
Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
por: Raveendran, Raji, et al.
Publicado: (2016) -
Platinum-RNA Modifications Following Drug Treatment
in S. cerevisiae Identified by Click Chemistry and
Enzymatic Mapping
por: Osborn, Maire F., et al.
Publicado: (2014) -
Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma
por: Moynihan, Eoin, et al.
Publicado: (2021)